Download by
Scanning QR Code
No Stock Yet
Loading...
No Stock Yet
No Data
Hillevax (HLVX) Stock: Why The Price Rose 6.42% Today
The stock price of Hillevax Inc (NASDAQ: HLVX) increased 6.42% today. This is why. The stock price of Hillevax Inc (NASDAQ: HLVX) increased 6.42% today. Investors responded positively to a bullish re
SVB Sees De-Risked Opportunity For This This Newly Listed Norovirus Vaccine
SVB Leerink is initiating coverage of HilleVax Inc (NASDAQ:HLVX) shares with an Outperform rating and a $30 price target. The analyst believes the company's potentially first-in-class infant norovirus
HilleVax Shares Rise Tuesday After Brokerages Start Coverage
01:55 PM EDT, 05/24/2022 (MT Newswires) -- HilleVax (HLVX) shares were up 9% by Tuesday afternoon after four brokerages started coverage of the biopharmaceutical company. Stifel began coverage at buy
HilleVax stock jumps 11% following four analyst buy ratings
Norovirus vaccine developer HilleVax (HLVX) saw its shares jump 11% in afternoon trading after four investment firms initiated coverage of the stock with buy ratings. Shares of HLVX opened at $9.81. T
What You Missed On Wall Street This Morning
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Snap (SNAP) shares cratered after the company tempered expectations for Q2 revenue and EBIT
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
Upgrades Susquehanna upgraded the previous rating for Lattice Semiconductor Corp (NASDAQ:LSCC) from Neutral to Positive. In the first quarter, Lattice Semiconductor showed an EPS of $0.37, compared to
HilleVax started at buy with $34 stock price target at Stifel Nicolaus
HilleVax started at buy with $34 stock price target at Stifel Nicolaus
HilleVax started at overweight with $24 stock price target at J.P. Morgan
HilleVax started at overweight with $24 stock price target at J.P. Morgan
HilleVax Initiated at Buy by Guggenheim
HilleVax Initiated at Buy by Guggenheim
HilleVax Price Target Announced at $40.00/Share by Guggenheim
HilleVax Price Target Announced at $40.00/Share by Guggenheim